Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 3 art units • 3 examiners • 0 of 4 (0%) have an AI response strategy ready
Metabolic Technologies, LLC manages a portfolio in the Biotechnology & Pharmaceuticals technology area with 4 pending office actions. These actions are distributed among 3 distinct examiners, indicating a varied examination experience. The prosecution is currently active across 3 distinct art units, which suggests the company's innovations span multiple specialized classifications. CHONG, YONG SOO is the busiest examiner for this portfolio, holding 2 pending office actions.
The 4 pending office actions are handled by the assigned examiners, ensuring that the workload is distributed. This presence in the art units reflects the technical diversity of the company's pending applications. CHONG, YONG SOO is responsible for the busiest examiner pending actions. This distribution shows that 2 of the pending office actions are managed by this specific examiner.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (50%) |
| Multi-statute (no §101) | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHONG, YONG SOO | 2 | 43.8% | +41.6% |
| PUTTLITZ, KARL J | 1 | 69.1% | +18.6% |
| NEAGU, IRINA | 1 | 46.8% | +57.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17076493 | METHOD OF ADMINISTERING BETA-HYDROXY-BETA-METHYLBUTYRATE (HMB) | CHONG, YONG SOO | 22d overdue |
| 16240211 | COMPOSITIONS AND METHODS OF USE OF BETA-HYDROXY-BETA-METHYLBUTYRATE (HMB) ASSOSIATED WITH INTERMITTENT FASTING | CHONG, YONG SOO | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17076493 | METHOD OF ADMINISTERING BETA-HYDROXY-BETA-METHYLBUTYRATE (HMB) | CHONG, YONG SOO | 22d overdue |
| 16952673 | COMPOSITIONS AND METHODS OF USE OF BETA-HYDROXY-BETA-METHYLBUTYRATE (HMB) FOR JOINT STABILITY | PUTTLITZ, KARL J | 10d overdue |
| 15348149 | COMPOSITIONS AND METHODS OF USE OF BETA-HYDROXY-BETA-METHYLBUTYRATE (HMB) AS AN ANIMAL FEED ADDITIVE | NEAGU, IRINA | 28d |
| 16240211 | COMPOSITIONS AND METHODS OF USE OF BETA-HYDROXY-BETA-METHYLBUTYRATE (HMB) ASSOSIATED WITH INTERMITTENT FASTING | CHONG, YONG SOO | — |
| Art Unit | Apps |
|---|---|
| 1623 | 2 |
| 1646 | 1 |
| 1629 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 16952673 | COMPOSITIONS AND METHODS OF USE OF BETA-HYDROXY-BETA-METHYLBUTYRATE (HMB) FOR JOINT STABILITY | PUTTLITZ, KARL J | 1646 | §103 | Non-Final OA | 10d overdue | Pending | Nov 19, 2020 |
| 17076493 | METHOD OF ADMINISTERING BETA-HYDROXY-BETA-METHYLBUTYRATE (HMB) | CHONG, YONG SOO | 1623 | §102§103 | Final Rejection | 22d overdue | Pending | Oct 21, 2020 |
| 16240211 | COMPOSITIONS AND METHODS OF USE OF BETA-HYDROXY-BETA-METHYLBUTYRATE (HMB) ASSOSIATED WITH INTERMITTENT FASTING | CHONG, YONG SOO | 1623 | §103§112 | Final Rejection | — | Pending | Jan 04, 2019 |
| 15348149 | COMPOSITIONS AND METHODS OF USE OF BETA-HYDROXY-BETA-METHYLBUTYRATE (HMB) AS AN ANIMAL FEED ADDITIVE | NEAGU, IRINA | 1629 | §103 | Final Rejection | 28d | Pending | Nov 10, 2016 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial